176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.56%
Revenue growth under 50% of INTC's 17.01%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
145.36%
Gross profit growth above 1.5x INTC's 32.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
136.55%
EBIT growth below 50% of INTC's 21591.67%. Michael Burry would suspect deeper competitive or cost structure issues.
136.55%
Operating income growth under 50% of INTC's 21591.67%. Michael Burry would be concerned about deeper cost or sales issues.
151.06%
Net income growth under 50% of INTC's 566.33%. Michael Burry would suspect the firm is falling well behind a key competitor.
151.85%
EPS growth under 50% of INTC's 578.20%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
151.85%
Diluted EPS growth under 50% of INTC's 564.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-2.09%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
1.64%
Diluted share count expanding well above INTC's 0.38%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-46.88%
Negative OCF growth while INTC is at 18.29%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-340.52%
Negative FCF growth while INTC is at 27.30%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
500.98%
10Y revenue/share CAGR above 1.5x INTC's 53.88%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
64.54%
5Y revenue/share CAGR above 1.5x INTC's 27.61%. David Dodd would look for consistent product or market expansions fueling outperformance.
44.33%
3Y revenue/share CAGR above 1.5x INTC's 11.94%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
165.97%
10Y OCF/share CAGR above 1.5x INTC's 28.72%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
544.73%
5Y OCF/share CAGR above 1.5x INTC's 45.39%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-52.03%
Negative 3Y OCF/share CAGR while INTC stands at 49.49%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
278.30%
Net income/share CAGR above 1.5x INTC's 52.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
765.55%
5Y net income/share CAGR above 1.5x INTC's 12.11%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-11.23%
Negative 3Y CAGR while INTC is 48.64%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1541.41%
10Y equity/share CAGR above 1.5x INTC's 60.64%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
119.46%
5Y equity/share CAGR above 1.5x INTC's 17.66%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
72.89%
3Y equity/share CAGR above 1.5x INTC's 16.14%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.54%
Firm’s AR is declining while INTC shows 4.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
21.22%
We show growth while INTC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-7.86%
Negative asset growth while INTC invests at 3.94%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.61%
We have a declining book value while INTC shows 1.01%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.26%
Our R&D shrinks while INTC invests at 9.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-2.22%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.